Professor Zimmet is Professor of Diabetes at Monash University and formerly Director Emeritus, Baker IDI Heart and Diabetes Institute. He is c-Director of the Sagol Family Center for Epigenetics at Tel Aviv Medical Center and an Honorary President of the IDF. He has an outstanding international record in diabetes and obesity research, both basic, and in epidemiology and public health research. His studies predicted then charted the evolving global type 2 diabetes epidemic. He has published over 1000 papers and is listed in both the 2015 and 2016 Thomson Reuter’s “Worlds-Most-Influential-Scientific-Minds”. He is co-editor of the widely used "International Textbook of Diabetes Mellitus" and co-editor of “The Epidemiology of Diabetes”. In the 2020 Google Scholar listings for high cited scientists, Paul is the 4th highest cited in Diabetes.. His international and national awards include the Kelly West and Harold Rifkin Medals (American Diabetes Association), Kellion Award (Australian Diabetes Society), Banting Award (Diabetes UK) and the A.M. Cohen Memorial Award and Lecture, EASD (Jerusalem 2000), the Hellmut Mehnert/German Diabetes Union Award, EASD (Munich 2004). He received the Grand Hamdan International Prize for Medical Sciences (Dubai) in 2010 and in 2013, the Peter Wills Medal from Research Australia recognising an Australian scientist who has made an outstanding contribution to building Australia’s international reputation in health and medical research. In 2015, he presented the International Diabetes Federation Award Lecture at the World Diabetes Congress in Vancouver. He is an International Member of the Spanish Royal National Academy of Medicine and holds Honorary Doctorates from Tel Aviv University, Madrid’s Complutense University, Monash University, and University of Adelaide. In 1993, he received the "Order of Australia (AM)" for distinguished services to medicine and education, and diabetes and in 2001, he received the honour of Officer of the Order (AO) for medical research of national and international significance and for contributions to Australia’s biotechnology development. He was Co-Chair of the National Diabetes Strategy Advisory Committee for the development of the 2016-2020 Strategy and in 2018, was recognised as the 2018 Senior Victorian Australian of the Year.